Creatine monohydrate does not increase strength in patients with hereditary neuropathy

Neurology

Volumn 57, Issue 3, 2001, Pages 559-560

  Doherty, Timothy J ^a,c   Lougheed, K ^b   Markez, J ^b   Tarnopolsky, M A ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; CREATINE PHOSPHATE; PLACEBO;

ARTICLE; CLIMBING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYNAMOMETRY; ENDURANCE; FATIGUE; GASTROINTESTINAL SYMPTOM; GRIP STRENGTH; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; IMPEDANCE; LEAN BODY WEIGHT; LEG CRAMP; MUSCLE STRENGTH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY;

EID: 0035859856     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.3.559     Document Type: Article

References (7)

1. The physiological and health effects of oral creatine supplementation
2. Creatine monohydrate increases strength in patients with neuromuscular disease
3. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies
4. Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study
5. A placebo-controlled crossover trial of creatine in mitochondrial diseases
6. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
7. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease